Mode
Text Size
Log in / Sign up

Feedback-regulated background infusion reduces postoperative nausea and vomiting in laparoscopic myomectomy patientsSmart pump cuts nausea after surgery without hurting pain control

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Recognize reduced PONV with feedback-regulated infusion in myomectomy patients, pending broader validation.

This single-center randomized controlled trial evaluated 132 patients undergoing laparoscopic myomectomy. The study compared feedback-regulated background infusion with adjustable rates of 1-4 mL/h against a constant-rate background infusion at 2 mL/h. The primary endpoint focused on the incidence of postoperative nausea and vomiting within 48 hours postoperatively.

The incidence of postoperative nausea and vomiting was significantly lower in the feedback-regulated group. Absolute numbers showed 41.7% in the feedback-regulated group versus 62.7% in the constant-rate group. The risk difference was -21.0% with a 95% confidence interval ranging from -38.1% to -3.9%. The risk ratio was 0.66 with a 95% confidence interval of 0.46 to 0.96. Statistical significance was reached with P = 0.022.

Secondary outcomes included pain scores, total opioid consumption, and patient satisfaction. Total sufentanil consumption was reduced in the feedback-regulated group by approximately 30% with P < 0.01. Pain scores were comparable between groups, though specific numbers were not reported. Patient satisfaction was significantly higher in the feedback-regulated group with P < 0.01.

Safety assessment noted no cases of respiratory depression in either group. Other adverse events were assessed, but serious adverse events and discontinuations were not reported. Limitations include the single-center setting and the need for validation in broader patient populations. Economic feasibility was not assessed. These findings suggest a favorable safety profile in this specific surgical population and may represent a promising strategy for opioid-sparing analgesia.

Imagine waking up from surgery feeling great. Then the nausea hits hard. It is a common side effect of pain medicine.

Many people need opioids after surgery. But too much causes vomiting. This stops people from eating or drinking.

Why nausea hits so hard after surgery

Doctors often use strong pain medicine after operations. These drugs help with pain but can make you sick. Nausea and vomiting are very common.

This problem is called PONV. It happens to many patients. It makes recovery much harder than it needs to be.

A smart pump that listens to pain

Doctors used to give a steady stream of medicine. This is called constant-rate background infusion. It keeps pain steady but can give too much drug.

Now a smart pump adjusts the flow. It listens to your pain signals. If you need more relief, it gives a bit more.

Think of a thermostat in your home. It turns heat up or down to keep the room comfortable. This pump does the same with pain meds.

It watches how often you press the button for extra pain relief. If you press it too much, it adds more medicine. If you go hours without pressing it, it slows down.

What changed in the new study results

Researchers tested this idea with 132 women. They all had surgery to remove fibroids. Half got the old pump. Half got the new smart one.

The new pump cut nausea by 21 percent. People used less pain medicine. Pain relief stayed the same.

Patient satisfaction was much higher with the smart pump. No one had trouble breathing in either group.

This does not mean the new pump is ready for your surgery.

Why this might not be everywhere yet

This is a promising step forward for pain management. But it is not in every hospital yet. You might not see it at your local clinic.

The study was small and focused on one type of surgery. We need more data before it becomes standard care.

Doctors will need to learn how to use the new system. Hospitals also need to buy the equipment.

What happens next for this technology

More research is needed to see if this works for other surgeries. Researchers want to check if it saves money too.

Approval takes time to ensure safety for everyone. You should talk to your doctor about pain plans before your operation.

The goal is to help people feel better faster. Less nausea means you can eat and drink sooner. This helps your body heal.

Scientists are working to make this technology available to more people. It could change how we manage pain after surgery.

For now, this is a hopeful sign for patients. It shows that technology can make recovery easier. We will watch for more updates on this smart pump.

Study Details

Study typeRct
Sample sizen = 132
EvidenceLevel 2
PublishedJan 2026
View Original Abstract ↓
BACKGROUND: Postoperative nausea and vomiting (PONV) remains a common and distressing side effect of opioid-based patient-controlled analgesia (PCA). Although continuous background infusion stabilizes analgesia, it often induces excessive opioid exposure and related adverse events. This study evaluates a novel smart PCA system featuring feedback-regulated background infusion (FRBI) designed to dynamically adjust opioid delivery based on real-time pain feedback, aiming to reduce PONV without compromising analgesia. METHODS: In this prospective, randomized, controlled, single-center trial, 132 patients undergoing laparoscopic myomectomy were assigned in a 1:1 parallel-group design to either constant-rate background infusion (CRBI) at 2 mL/h (Group A) or FRBI with adjustable rates of 1-4 mL/h (Group B). Both groups received a standardized sufentanil-flurbiprofen solution via PCA. The FRBI algorithm dynamically adjusted the infusion rate: a 20% increase was triggered by ≥2 bolus demands within 30 minutes, and a 20% decrease followed 4 consecutive demand-free hours. The primary outcome was the incidence of PONV (defined as nausea and/or vomiting) within 48 hours postoperatively. Secondary outcomes included pain scores (NRS), total opioid consumption, occurrence of other adverse events, and patient satisfaction. RESULTS: The FRBI group demonstrated a significantly lower incidence of PONV (nausea and/or vomiting) compared to the CRBI group (41.7% vs 62.7%, risk difference: -21.0% [95% CI: -38.1% to -3.9%]; risk ratio: 0.66 [95% CI: 0.46 to 0.96], P = 0.022). Total sufentanil consumption was reduced by approximately 30% in the FRBI group (P < 0.01). Pain scores were comparable between groups at all time points. Patient satisfaction was significantly higher in the FRBI group (P < 0.01). No cases of respiratory depression were observed in either group. CONCLUSION: The feedback-regulated background infusion mode significantly reduces the incidence of PONV and total opioid consumption while maintaining effective analgesia in patients undergoing laparoscopic myomectomy. This strategy suggests a favorable safety profile in this specific surgical population and may represent a promising strategy for opioid-sparing analgesia. Further studies are needed to validate these findings in broader patient populations and to assess economic feasibility.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.